Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Validity of mobile electronic data capture in clinical studies: a pilot study in a pediatric population.

von Niederhäusern B, Saccilotto R, Schädelin S, Ziesenitz V, Benkert P, Decker ML, Hammann A, Bielicki J, Pfister M, Pauli-Magnus C.

BMC Med Res Methodol. 2017 Dec 8;17(1):163. doi: 10.1186/s12874-017-0438-x.

2.

Development of Drug Therapies for Newborns and Children: The Scientific and Regulatory Imperatives.

Mulugeta YL, Zajicek A, Barrett J, Sachs HC, McCune S, Sinha V, Yao L.

Pediatr Clin North Am. 2017 Dec;64(6):1185-1196. doi: 10.1016/j.pcl.2017.08.015. Review.

PMID:
29173779
3.

Advancing the Quality of Pediatric Antipsychotic Use: Maybe It Takes a PAL.

Zito JM.

Health Serv Res. 2017 Apr;52(2):555-560. doi: 10.1111/1475-6773.12671. No abstract available.

PMID:
28297076
4.

Pediatric Dosing and Body Size in Biotherapeutics.

Shi R, Derendorf H.

Pharmaceutics. 2010 Dec 16;2(4):389-418. Review.

5.

Newborns still lack drug data to guide therapy.

Ward RM, Sherwin CM.

Br J Clin Pharmacol. 2016 Dec;82(6):1410-1411. doi: 10.1111/bcp.13074. Epub 2016 Oct 3. No abstract available.

6.

Designing a Pediatric Study for an Antimalarial Drug by Using Information from Adults.

Petit C, Jullien V, Samson A, Guedj J, Kiechel JR, Zohar S, Comets E.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1481-91. doi: 10.1128/AAC.01125-15.

7.

Informed consent in paediatric critical care research--a South African perspective.

Morrow BM, Argent AC, Kling S.

BMC Med Ethics. 2015 Sep 9;16:62. doi: 10.1186/s12910-015-0052-6.

8.

Regulating off-label drug use in India: The arena for concern.

Oberoi SS.

Perspect Clin Res. 2015 Jul-Sep;6(3):129-33. doi: 10.4103/2229-3485.159935. Review.

9.

Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Czaja AS, Reiter PD, Schultz ML, Valuck RJ.

J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):186-96. doi: 10.5863/1551-6776-20.3.186.

10.

Anesthetic use in newborn infants: the urgent need for rigorous evaluation.

Nasr VG, Davis JM.

Pediatr Res. 2015 Jul;78(1):2-6. doi: 10.1038/pr.2015.58. Epub 2015 Mar 19. Review.

11.

Developmental pharmacokinetics in pediatric populations.

Lu H, Rosenbaum S.

J Pediatr Pharmacol Ther. 2014 Oct-Dec;19(4):262-76. doi: 10.5863/1551-6776-19.4.262. Review.

12.

Improving the outcome for children with cancer: Development of targeted new agents.

Adamson PC.

CA Cancer J Clin. 2015 May-Jun;65(3):212-20. doi: 10.3322/caac.21273. Epub 2015 Mar 9. Review.

13.

Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.

Salpietro V, Polizzi A, Di Rosa G, Romeo AC, Dipasquale V, Morabito P, Chirico V, Arrigo T, Ruggieri M.

Int J Endocrinol. 2014;2014:282489. doi: 10.1155/2014/282489. Epub 2014 Sep 3. Review.

14.

Paediatric clinical pharmacology in the UK.

Choonara I, Sammons H.

Arch Dis Child. 2014 Dec;99(12):1143-6. doi: 10.1136/archdischild-2014-306853. Epub 2014 Sep 8. Review.

15.

Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology.

Mussap M, Noto A, Fanos V, Van Den Anker JN.

Biomed Res Int. 2014;2014:602526. doi: 10.1155/2014/602526. Epub 2014 Jun 11. Review.

16.

Anti-hypertensive drugs in children and adolescents.

Chu PY, Campbell MJ, Miller SG, Hill KD.

World J Cardiol. 2014 May 26;6(5):234-44. doi: 10.4330/wjc.v6.i5.234. Review.

17.

Diuretic exposure in premature infants from 1997 to 2011.

Laughon MM, Chantala K, Aliaga S, Herring AH, Hornik CP, Hughes R, Clark RH, Smith PB.

Am J Perinatol. 2015 Jan;32(1):49-56. doi: 10.1055/s-0034-1373845. Epub 2014 May 6.

18.

10-year trend in quantity and quality of pediatric randomized controlled trials published in mainland China: 2002-2011.

Yang CS, Zhang LL, Zeng LN, Liang Y, Han L, Lin YZ.

BMC Pediatr. 2013 Aug 2;13:113. doi: 10.1186/1471-2431-13-113.

19.

Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Willmann S, Becker C, Burghaus R, Coboeken K, Edginton A, Lippert J, Siegmund HU, Thelen K, Mück W.

Clin Pharmacokinet. 2014 Jan;53(1):89-102. doi: 10.1007/s40262-013-0090-5.

20.

The bad taste of medicines: overview of basic research on bitter taste.

Mennella JA, Spector AC, Reed DR, Coldwell SE.

Clin Ther. 2013 Aug;35(8):1225-46. doi: 10.1016/j.clinthera.2013.06.007. Epub 2013 Jul 22. Review.

Supplemental Content

Support Center